Dual egg retrieaval for poor prognosis wome

Phase 1

• Conditions: infertility; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]

• Registration Number: EUCTR2019-000971-17-BE
• Lead Sponsor: Z Brussel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-14
• Last Update Posted: 12 March 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Female
• Target Recruitment: 46

Inclusion Criteria

- Age 25-40 years
- BMI = 35 and = 19
-Antimüllerian hormone (AMH) level of =1.5 ng/mL or antral follicular count of =6 follicles or =5 oocytes retrieved in a previous cycle following standard conventional ovarian stimulation.
- =9 follicles >11 mm on the day of first trigger

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 46
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

history of more than three consecutive previous unsuccessful IVF/ICSI cycles, BMI >35 or <19, PCOS according to the Rotterdam criteria, ovarian stimulation for for pre-implantation genetic testing (PGT-A/M), medical/social freezing, in vitro maturation (IVM), use of oral contraceptives >3 months before start of the treatment, testicular sperm extraction; history of untreated autoimmune, endocrine or metabolic disorders, ovarian cystectomy or oophorectomy.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified